Home > Newsletters > FDAnews Device Daily Bulletin > Boston Scientific Launches New Implantable Defibrillation Lead In Europe, Asia
FDAnews Device Daily Bulletin
Sept. 26, 2012 | Vol. 9 No. 189
Boston Scientific Launches New Implantable Defibrillation Lead In Europe, Asia
Boston Scientific has received regulatory approval to market the RELIANCE 4-FRONT lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.
The Sacramento Bee
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.